Medipixel
Medipixel is a MedTech startup founded in 2017, focusing on cardiovascular intervention with AI-powered real-time analysis solutions. Their flagship products include MPXA, an AI medical device for real-time analysis of cardiovascular conditions during procedures, and MPNeuro, an AI solution for cerebrovascular diagnosis and simulation. Medipixel aims to improve patient outcomes and streamline medical workflows through its advanced AI technology. The company has achieved significant milestones including regulatory approvals from the Korean Ministry of Food and Drug Safety and the US FDA for its products, and holds over 35 patents. Medipixel has also established over 20 partnerships globally and secured over 200 billion KRW in cumulative investment.
Medipixel
Medipixel is a MedTech startup founded in 2017, focusing on cardiovascular intervention with AI-powered real-time analysis solutions. Their flagship products include MPXA, an AI medical device for real-time analysis of cardiovascular conditions during procedures, and MPNeuro, an AI solution for cerebrovascular diagnosis and simulation. Medipixel aims to improve patient outcomes and streamline medical workflows through its advanced AI technology. The company has achieved significant milestones including regulatory approvals from the Korean Ministry of Food and Drug Safety and the US FDA for its products, and holds over 35 patents. Medipixel has also established over 20 partnerships globally and secured over 200 billion KRW in cumulative investment.